Use these selected concepts to connect periodontal science with diagnostic interpretation and clinical decisions for the American Board of Periodontology (ABP) Qualifying Examination. Each concept identifies a central rule, a resolved example and a specific mistake to avoid. Use the complete official 2027 outline in the references to plan your broader preparation.
Foundational mechanisms and evidence interpretation
1. Biofilm and inflammatory tissue destruction
Periodontitis is a chronic multifactorial inflammatory disease associated with dysbiotic plaque biofilms, and loss of periodontal tissue support due to inflammation is its primary feature, manifested through clinical attachment loss and radiographic alveolar bone loss rather than visible plaque alone.
Worked example: A 52-year-old patient presents with interproximal attachment loss and radiographically assessed alveolar bone loss at two non-adjacent teeth, documenting inflammatory destruction of the tooth-supporting apparatus beyond mere plaque accumulation.
Mistake to avoid: Diagnosing periodontitis solely because one microorganism is detected or heavy plaque is visible.
Reference: [3]
2. Build a clinically useful diabetes history
A dental diabetes history should establish the documented type, medications, monitoring method, most recent HbA1c, episodes of hypoglycemia or hyperglycemia, and related complications; history alone does not establish metabolic stability, so physician coordination may be needed.
Worked example: A 52-year-old with documented type 2 diabetes lists metformin but cannot recall her latest HbA1c, so the history also covers her monitoring routine, prior hypoglycemic episodes and diabetes-related complications before physician coordination is considered.
Mistake to avoid: Treating the recorded diagnosis label alone as a complete assessment of current metabolic control.
Reference: [10]
3. Bone remodeling and antiresorptive action
Bone remodeling relies on a balance between osteoclastic resorption and osteoblastic formation; antiresorptive agents suppress resorption by inhibiting osteoclasts, while romosozumab is anabolic, stimulating new bone formation as well as decreasing resorption.
Worked example: A postmenopausal woman taking a bisphosphonate has reduced osteoclastic resorption because the drug inhibits osteoclasts at remodeling sites; this mechanism does not demonstrate direct stimulation of osteoblastic bone formation.
Mistake to avoid: Assuming every osteoporosis medication suppresses osteoclasts identically, ignoring romosozumab's additional bone-forming effect.
Reference: [7]
4. Identify anticoagulant targets accurately
Warfarin is a vitamin K antagonist; dabigatran directly inhibits thrombin, whereas apixaban, rivaroxaban and edoxaban inhibit factor Xa, so these oral anticoagulants belong to distinct pharmacological classes with different molecular targets.
Worked example: A patient scheduled for periodontal surgery reports taking apixaban, which identifies a factor Xa inhibitor rather than a direct thrombin inhibitor, though drug identification alone does not determine the perioperative plan.
Mistake to avoid: Recording apixaban as a direct thrombin inhibitor like dabigatran in the patient's medication history.
Reference: [8]
5. Assigned exposure versus observed exposure
An experimental study is defined by the investigator determining each participant's exposure through a controlled process, whereas an observational study simply records existing exposure and disease status. Following participants over time does not by itself make a study experimental, and random assignment is one experimental method rather than a requirement of every experiment.
Worked example: A periodontist assigns fifty patients to receive one of two plaque-control instruction protocols and follows both groups for six months; because she determines the exposure, this is experimental, unlike recording patients' existing flossing habits.
Mistake to avoid: Labeling a study experimental merely because participants are followed over time.
Reference: [13]
6. Cohort studies follow exposure groups
In a cohort study, subjects are grouped by exposure and followed to document disease occurrence; the investigator observes rather than assigns exposure. Substantively different disease rates mean the exposure is said to be associated with illness. Retrospective cohorts use exposure and outcome data that already exist, and the design alone establishes neither association nor causation.
Worked example: Investigators record which factory workers smoke, then follow both groups for two years; the smoking group develops new periodontitis at a substantively higher rate, so smoking is said to be associated with the disease.
Mistake to avoid: Calling a two-group cohort study case-control simply because two groups are compared.
Reference: [13]
7. Case-control studies begin with disease status
In a case-control study, subjects are enrolled according to whether they have the disease, then prior exposures are compared with a control group comparable to the cases in most respects, which estimates the baseline or expected exposure in that population. This exposure comparison does not directly measure population disease incidence.
Worked example: Investigators enroll patients with peri-implantitis and comparable patients without it, then compare earlier smoking histories; the controls estimate expected baseline exposure, but the comparison does not directly measure population disease incidence.
Mistake to avoid: Selecting controls whose exposure experience poorly represents the population that produced the cases.
Reference: [13]
8. Cross-sectional findings describe a snapshot
Cross-sectional studies measure exposure and disease status simultaneously, assessing prevalence at one point in time; they are better suited to descriptive epidemiology than causation. Prevalence can reflect both disease occurrence and survival with disease, so no quantitative causal effect should be inferred from this design alone.
Worked example: A single-visit survey records which residents currently smoke and which currently have periodontitis, describing contemporaneous prevalence and association without showing whether smoking preceded periodontitis or affected survival with disease.
Mistake to avoid: Translating a one-time snapshot association into a proven disease-causing sequence.
Reference: [13]
9. Check whether a study population matches the patient
Favorable Type 1A survival findings for immediate placement and immediate restoration/loading of a single anterior maxillary tooth come from highly selected patients and sites with favorable characteristics, so those outcomes cannot be promised to patients whose circumstances differ. This is an applicability assessment, not a claim that the protocol lacks evidence.
Worked example: A patient with a thin facial bone wall and an extraction-site endodontic infection should not be told she will achieve the survival rates reported in the favorable selected Type 1A study populations.
Mistake to avoid: Quoting the published Type 1A survival rate as a guaranteed outcome for every anterior maxilla patient.
Reference: [5]
Diagnosis and classification
10. Attachment loss must meet the case definition
A periodontitis case requires interdental attachment loss at two or more nonadjacent teeth, or buccal/oral attachment loss of at least 3 mm with pocketing of at least 3 mm at two or more teeth, provided the loss cannot be ascribed to non-periodontitis causes. Apply the definition with clinical judgment.
Worked example: A patient shows 4 mm buccal attachment loss with 3 mm pocketing at two teeth, but the recession followed traumatic toothbrush injury, so the case definition of periodontitis is not met.
Mistake to avoid: Diagnosing periodontitis from isolated recession caused by aggressive traumatic toothbrushing rather than periodontitis.
Reference: [3]
11. Stage incorporates management complexity
Staging begins with clinical attachment loss, or radiographic bone loss when unavailable; tooth loss primarily attributable to periodontitis may modify the stage, complexity factors shift it higher, and further complexity assessment distinguishes stage III from IV; the supplied passages omit the full numerical table.
Worked example: A patient's attachment loss suggests stage II, but a class II furcation on a first molar shifts the diagnosis to stage III, with further complexity assessment needed to distinguish stage IV.
Mistake to avoid: Assigning stage II because attachment loss is mild while ignoring an untreated class II furcation involvement.
Reference: [3]
12. Grade prioritizes progression evidence
Grade reflects progression rate: use direct evidence whenever available; otherwise use indirect evidence such as radiographic bone loss as a percentage of root length divided by age at the most affected tooth. Assume grade B initially and seek evidence to shift toward grade A or C; risk factors can then modify the established grade.
Worked example: A 50-year-old shows 30% bone loss at the most affected tooth; the ratio 30 divided by 50 equals 0.6, an indirect progression input, while available longitudinal radiographs showing rapid loss would instead be used directly.
Mistake to avoid: Skipping longitudinal radiographs that document progression and grading the patient solely from the bone-loss-to-age ratio.
Reference: [3]
13. Quantify pocket burden beyond the disease label
A meaningful periodontal description reports the number and proportion of teeth whose probing depths exceed specified thresholds, commonly at least 4 mm and at least 6 mm; this descriptive proportion complements attachment-level and radiographic assessment, always specifying the threshold, denominator and unit of analysis.
Worked example: In an adult with 24 examined teeth, six show at least one site 6 mm or deeper, so the tooth-level proportion is 6 divided by 24, or 25%, reported with threshold and denominator.
Mistake to avoid: Reporting 25% as the proportion of all measured sites instead of the tooth-level proportion.
Reference: [3]
14. Recognize the periodontal abscess pattern
A periodontal abscess is an acute lesion with localized pus within the gingival wall of the pocket or sulcus, rapid tissue destruction, and risk of systemic dissemination; individual findings support assessment and prompt clinical evaluation rather than routine chronic-pocket management.
Worked example: A patient reports urgent pain at a lower molar where examination notes an ovoid lateral gingival elevation, suppuration on probing, a deep pocket, and increased mobility, supporting assessment for a periodontal abscess.
Mistake to avoid: Managing an acutely painful ovoid gingival swelling as routine chronic pocketing without any differential diagnosis.
Reference: [3]
15. Distinguish necrotizing gingivitis from periodontitis
Necrotizing gingivitis is an acute gingival process with interdental papilla necrosis or ulceration, bleeding, and pain; when rapid bone loss is also present, the presentation supports assessment as necrotizing periodontitis, with host immune impairment considered.
Worked example: A stressed adult smoker presents with punched-out necrotic interdental papillae, bleeding, halitosis, and pain, and radiographs show rapid bone loss, supporting assessment for necrotizing periodontitis rather than gingivitis alone.
Mistake to avoid: Labelling every painful bleeding gingiva as necrotizing disease without checking the characteristic papillary features.
Reference: [3]
16. Combine periodontal and pulp findings
An endo-periodontal lesion is a pathological communication between pulpal and periodontal tissues, occurring in acute or chronic form; deep pockets extending to the apex and altered pulp-test responses are key clues that must be integrated with imaging and root-damage findings.
Worked example: A molar shows a deep pocket tracing toward the apex, a dull response on pulp vitality testing, and radiographic furcation bone loss, so the clinician integrates these inputs in an endodontic-periodontal assessment.
Mistake to avoid: Diagnosing an endodontic-periodontal lesion from pocket depth alone while ignoring pulp testing and root-damage evidence.
Reference: [3]
17. Image immediate implant sites for position and stability
For single-tooth immediate placement and restoration or loading in the maxillary esthetic zone, the 2023 ITI guidance strongly recommends a good-quality periapical radiograph plus CBCT to assess the facial bone plate, bone for primary stability, and adjacent teeth.
Worked example: Before planning Type 1A treatment for a failing maxillary central incisor, the clinician obtains a clear periapical image and a CBCT, confirming an intact facial plate and healthy neighboring teeth.
Mistake to avoid: Treating a satisfactory two-dimensional periapical view as sufficient and skipping the recommended CBCT assessment.
Reference: [5]
Etiology and contributing factors
18. Abscess formation involves failed local defense
A periodontal abscess may begin when bacterial invasion or foreign-body impaction in the soft tissues around a pocket triggers inflammation; if the neutrophil-mediated defense fails, degranulation and necrosis can follow, producing pus accumulation.
Worked example: A previously periodontally healthy site develops a fluctuant swelling after a popcorn husk lodges in the gingival tissues, and pus forms when local neutrophil defense fails.
Mistake to avoid: Assuming every periodontal abscess must have arisen from longstanding untreated periodontitis.
Reference: [3]
19. Separate established risk factors from uncertain interaction
Diabetes and smoking are each recognized risk factors for periodontitis. Some evidence suggests they may act synergistically, but the responsible mechanisms remain unclear, so no combined risk estimate or fixed multiplicative rule is supported.
Worked example: A smoker with type 2 diabetes is documented as having two recognized periodontitis risk factors, while the chart notes that any synergistic interaction remains mechanistically uncertain.
Mistake to avoid: Multiplying the two patients' risk factors into a precise combined periodontitis risk figure.
Reference: [10]
20. Assess immune impairment in necrotizing disease
Necrotizing periodontal diseases are strongly associated with impaired host immunity, in chronically, severely compromised patients—where disease may be severe or life-threatening—and in temporarily or moderately compromised patients, such as smokers or psychosocially stressed adults. History and presentation guide assessment; the association alone does not establish the underlying immune diagnosis.
Worked example: A psychosocially stressed smoker presents with a necrotizing periodontitis lesion, prompting review of his history and immune context; the lesion does not establish profound immunodeficiency, though severely compromised patients may have severe or life-threatening disease.
Mistake to avoid: Concluding that every necrotizing lesion signifies AIDS rather than possible temporary immune compromise.
Reference: [3]
21. Distinguish systemic-disease periodontitis from risk modification
The classification recognizes three distinct forms: necrotizing periodontitis, periodontitis as a direct manifestation of systemic diseases, and periodontitis. A direct manifestation is classified through the primary disease's ICD code, while systemic risk modifiers such as diabetes do not by themselves define this category.
Worked example: A patient with a confirmed rare immune disorder that directly manifests as periodontitis is classified through that primary disorder, whereas a diabetic patient's periodontitis remains ordinary periodontitis with diabetes recorded as a risk modifier.
Mistake to avoid: Classifying a diabetic patient's periodontitis as a direct systemic-disease manifestation based on the comorbidity alone.
Prognostic interpretation
22. Root damage changes endodontic-periodontal prognosis
Root perforation, fracture or cracking, and external root resorption drastically impair prognosis in endo-periodontal lesions. Pulpal, periodontal and root-damage findings are assessed together; absent confirmed root damage alone establishes neither normal pulpal status nor favorable prognosis, and the adverse association does not indicate extraction.
Worked example: Two molars with similar deep pockets toward the apex both receive integrated pulpal and periodontal assessment; one has a confirmed iatrogenic root perforation, so its prognosis is markedly worse, while the other's rests on combined findings.
Mistake to avoid: Skipping pulp vitality testing and judging pulpal status from probing depths alone.
Reference: [3]
23. Thin buccal bone affects implant tissue outcomes
In healed sites, implants placed with thin buccal bone walls and no simultaneous bone augmentation are prone to less favorable clinical outcomes, including increased peri-implant probing pocket depth, bleeding on probing, suppuration, or mucosal recession, and less favorable radiographic outcomes. This describes susceptibility rather than inevitable disease or failure, and other patient, site, and treatment factors remain relevant.
Worked example: A healed site permits stable implant insertion, but its thin facial wall receives no simultaneous augmentation, so the plan documents increased risk of recession and deeper probing pockets rather than assuming favorable tissue conditions.
Mistake to avoid: Equating successful implant insertion into a thin-walled healed ridge with guaranteed long-term peri-implant health.
Reference: [4]
24. Glycemic control qualifies implant prognosis
Implant procedures are safe and predictable in patients with well-controlled diabetes, whereas poorly controlled disease may cause delayed osseointegration and a less predictable prognosis. No universal HbA1c eligibility cutoff is provided, so complications, current control, and the proposed procedure are assessed with appropriate medical input, and predictability never guarantees an individual outcome.
Worked example: A patient with stable glycemic control and physician clearance undergoes implant placement with predictable expectations, whereas a peer with persistently poor control receives additional risk assessment and medical coordination first.
Mistake to avoid: Declaring every patient with a diabetes diagnosis unsuitable for implant treatment without assessing glycemic control.
Reference: [10]
25. Interpret when Type 1A failures occur
In the ITI-summarized Type 1A studies of single-tooth anterior-maxillary immediate placement with immediate restoration, most failures occurred within the first six months; these highly selective populations do not define an individual implant's later failure probability.
Worked example: An implant placed immediately in a maxillary incisor site with immediate loading fails at four months, matching the reported pattern; a surviving implant is not thereby immune to later failure.
Mistake to avoid: Assuming a patient's implant cannot fail after six months because most reported failures occurred earlier.
Reference: [5]
Treatment planning and medical risk
26. Balance dental bleeding against thrombotic harm
For most dental patients, it is not necessary to alter anticoagulation or antiplatelet therapy before dental intervention; local measures control bleeding, while stopping these drugs raises thrombotic risk. Evidence is stronger for warfarin and antiplatelet agents than for direct-acting oral anticoagulants, and any regimen modification requires consultation with the patient's physician.
Worked example: A periodontal patient taking clopidogrel needs two extractions; the dentist plans local hemostatic measures, keeps the antiplatelet unchanged, and contacts the physician before considering any regimen change.
Mistake to avoid: Discontinuing the patient's antiplatelet before a routine extraction because anticipated dental bleeding seems easier to manage.
Reference: [8]
27. Endocarditis prophylaxis requires patient and procedure eligibility
Endocarditis prophylaxis requires both a highest-risk cardiac condition—such as a prosthetic valve, prior endocarditis, or specified congenital or transplant-related conditions—and a dental procedure manipulating gingiva or periapical tissue or perforating oral mucosa; verify the exact condition and applicable guidance.
Worked example: A patient with a transcatheter-implanted aortic valve undergoes scaling with gingival manipulation, satisfying both the cardiac-condition and procedure requirements; a different cardiac diagnosis alone would not establish an indication.
Mistake to avoid: Premedicating any patient with a cardiac diagnosis without checking whether the condition and procedure both qualify.
Reference: [9]
28. A prosthetic joint does not automatically require prophylaxis
Routine antibiotic prophylaxis is generally not recommended before dental procedures solely to prevent prosthetic joint infection; rare individualized exceptions involve shared decision-making, particularly when patients with previous joint-replacement complications undergo procedures with gingival manipulation or mucosal incision.
Worked example: A patient with an uncomplicated total knee replacement needs restorative dentistry without gingival manipulation; no premedication is indicated, whereas a complicated replacement history would prompt shared assessment with the orthopedic team.
Mistake to avoid: Automatically prescribing prophylactic antibiotics for every hip-replacement patient before dental treatment instead of pursuing shared decision-making.
Reference: [9]
29. Antiresorptive risk depends on treatment context
MRONJ risk assessment weighs treatment indication, distinguishing osteoporosis dosing from the higher dosages and more frequent cancer-related schedules, alongside duration beyond two years, periodontitis or dentures; these factors inform assessment but cannot identify who will develop MRONJ.
Worked example: Two patients on the same bisphosphonate are assessed differently: one takes an osteoporosis dose for two years with periodontitis, while the other receives a higher-dose, more frequent cancer-related regimen, so their risk discussions differ.
Mistake to avoid: Assigning both patients the same MRONJ risk category based on the shared drug name alone.
Reference: [7]
30. Plan implant alternatives before extraction
Before extraction, both the implant placement and loading protocol should be planned, with selection matched to patient and site conditions and clinician experience. Alternative treatment modalities must be prepared in case intraoperative criteria, such as adequate primary stability, are not met.
Worked example: In a Type 1A maxillary esthetic-zone case, insufficient bone apical and lingual to the socket prevents primary stability in the ideal restoration-driven position, so the prepared alternative provisional is delivered and the implant plan reassessed.
Mistake to avoid: Promising the patient a fixed immediate crown at consent without preparing any alternative provisional restoration.
31. Coordinate changes in eating with diabetes medication
When a dental procedure will change a patient's food intake, a plan balancing diabetes medications and food intake should be established in advance, and medication dosing may need modification in consultation with the patient's physician.
Worked example: Before surgical extraction under sedation that will limit eating afterward, the dentist contacts the patient's physician to arrange a plan balancing medication doses with the expected reduced intake, rather than leaving the regimen unchanged.
Mistake to avoid: Telling a patient to simply take her usual insulin dose despite planned postoperative meals of only liquids.
Reference: [10]
Periodontal therapy in medical risk settings
32. Provide periodontal care alongside diabetes management
Despite inconsistent evidence that periodontal therapy improves glycemic control, patients with diabetes benefit from periodontal treatment combined with good oral health maintenance at home, so care should not be made conditional on demonstrating an HbA1c reduction.
Worked example: A patient with type 2 diabetes and generalized periodontitis receives scaling and root planing plus home-care instruction; when HbA1c is unchanged afterward, the dentist continues supportive periodontal care rather than dismissing its value.
Mistake to avoid: Declining further periodontal treatment because the patient's HbA1c did not decrease after therapy.
Reference: [10]
33. MRONJ can occur without dental intervention
Although medication-related osteonecrosis of the jaw is associated with bone-invasive dental procedures such as tooth extraction, it can also occur without dental intervention, so the absence of recent surgery does not exclude MRONJ in a patient taking bisphosphonates, denosumab, or romosozumab.
Worked example: A patient taking denosumab presents with exposed mandibular bone despite never having had an extraction or other dentoalveolar surgery; the clinician still considers medication-related osteonecrosis rather than dismissing it for lack of a procedure.
Mistake to avoid: Excluding MRONJ from the differential because the patient reports no recent extraction or bone-invasive dental procedure.
Reference: [7]
34. Local hemostasis is part of bleeding management
For dental patients taking antithrombotic medication, bleeding can often be controlled with local measures such as mechanical pressure, hemostatic agents, suturing, or antifibrinolytics like tranexamic acid, so postoperative bleeding is assessed for local control rather than defaulting to withdrawal of prescribed medication.
Worked example: After extracting two teeth in a patient continuing apixaban, the dentist controls oozing with pressure, a hemostatic agent and suturing, considering local control before any suggestion of altering the prescribed anticoagulant regimen with the physician.
Mistake to avoid: Defaulting to stopping a patient's anticoagulant after minor oozing instead of applying pressure and local hemostatic measures.
Reference: [8]
35. Apply Standard Precautions to every patient
Standard Precautions are the minimum infection prevention practices applied to all patient care regardless of suspected or confirmed infection status, including hand hygiene, personal protective equipment, sharps safety, safe injections, sterile instruments and clean surfaces; Transmission-Based Precautions only supplement them when needed.
Worked example: An apparently healthy patient scheduled for periodontal scaling still receives the full standard measures—hand hygiene, gloves, mask and eyewear, sterile instruments—while a patient with a transmissible infection may additionally require Transmission-Based Precautions.
Mistake to avoid: Relying on a reassuring medical history to skip baseline precautions for an asymptomatic patient.
Reference: [12]
Implant placement and tissue considerations
36. Use restoration-driven digital implant planning
For the 2023 ITI Type 1A maxillary esthetic-zone guidance, when a CBCT volume has been captured, implant planning software is strongly recommended to simulate the ideal 3D position, analyzing the tooth–alveolus axis for restoration-driven placement, the facial gap at the planned implant shoulder, and abutment options.
Worked example: In planning software for a maxillary incisor site, the clinician simulates a restoration-driven 3D implant position, checks the facial gap at the planned shoulder and abutment options, rather than accepting the ridge axis alone.
Mistake to avoid: Accepting an anatomically favorable ridge axis without evaluating whether the simulated position aligns with the intended restoration.
Reference: [5]
37. Consider ridge preservation when late placement is indicated
The 2018 ITI consensus identifies alveolar ridge resorption and reduced bone volume as disadvantages of planned late implant placement, and recommends ridge preservation when late placement is indicated for patient- or site-related reasons, without specifying graft material, technique, or timing.
Worked example: A patient needing delayed implant placement for site-related reasons is assessed for ridge preservation, since the ITI expects postponement to risk ridge resorption rather than leave dimensions unchanged.
Mistake to avoid: Assuming delayed implant placement leaves ridge dimensions unchanged, so ridge preservation is never considered.
Reference: [6]
38. Interpret regeneration evidence for buccal dehiscence
In one small randomized trial (22 patients, 28 implants), simultaneous guided bone regeneration at implants with buccal dehiscence defects showed less vertical bone loss and more favorable clinical and radiographic outcomes than nonaugmented defects during initial healing; no graft material or sequence is specified.
Worked example: An implant placed with primary stability shows a buccal dehiscence, so the clinician weighs simultaneous guided bone regeneration while recognizing the limited trial evidence rather than expecting a guaranteed outcome.
Mistake to avoid: Ignoring a buccal dehiscence because the implant achieved good primary stability at placement.
Reference: [4]
39. Hard tissue augmentation may not resolve soft tissue esthetics
The healed-site buccal bone consensus notes that although simultaneous bone augmentation usually achieves satisfactory esthetic results, high-esthetic-demand patients with a thin soft tissue phenotype or deficiency may need an additional soft tissue augmentation; this is not a universal grafting requirement.
Worked example: After bone augmentation restores a bony contour in a high-esthetic-demand patient with thin soft tissue, the team considers additional soft tissue augmentation because the deficiency may persist independently.
Mistake to avoid: Assuming bone augmentation alone resolves thin soft tissue in a high-esthetic-demand case.
Reference: [4]
40. Chronic periapical infection requires conditional selection
The 2023 ITI guidance permits selecting the Type 1A protocol for teeth with chronic periapical infection only when there is no fistula, the infection can be completely debrided, and sufficient bone remains to provide primary implant stability.
Worked example: A maxillary esthetic-zone tooth has chronic periapical infection without a fistula, completely debridable lesions, and adequate bone for primary stability, so Type 1A may be considered by experienced clinicians.
Mistake to avoid: Treating chronic periapical infection as irrelevant to Type 1A selection, ignoring fistula and debridement conditions.
Reference: [5]
41. Facial tissue defects can change the immediate protocol
In the 2023 Type 1A guidance for selected single-tooth maxillary esthetic-zone immediate placement, minor facial defects and thin tissues increase esthetic risk and complexity, possibly requiring adjunctive regenerative procedures, while larger defects require considering alternative protocols.
Worked example: During a planned Type 1A immediate placement, extraction reveals a major facial wall defect; the clinician reassesses and considers alternative protocols rather than automatically completing the intended single-tooth esthetic-zone protocol.
Mistake to avoid: Calling a thin-tissue phenotype case routine and low risk despite the guidance's increased-complexity warning.
Reference: [5]
Evaluation and continuing care
42. Successful treatment does not lower the original stage
When treatment eliminates a stage-shifting complexity factor, the stage should not retrogress; the original complexity factor remains relevant to maintenance management, even though current findings still require reevaluation and the documented improvement is real.
Worked example: A patient whose stage IV periodontitis included posterior bite collapse returns after treatment with the collapse corrected; the clinician documents improved findings but retains stage IV because original complexity informs maintenance.
Mistake to avoid: Reclassifying the patient to a lower stage after treatment resolved the bite collapse.
Reference: [3]
43. Continue glycemic risk assessment throughout implant care
Systematic reviews advise considering HbA1c values for risk assessment before implant placement and throughout the implant's lifespan, with hyperglycemia regarded as a significant risk factor associated with peri-implant inflammation; no universal recall interval or cutoff is established.
Worked example: Years after uneventful implant restoration, a patient's physician reports deteriorating diabetes control; the dentist renews glycemic risk assessment alongside clinical peri-implant examination instead of assuming the preoperative HbA1c still applies.
Mistake to avoid: Assuming good glycemic control documented at surgery permanently removes later peri-implant inflammation risk.
Reference: [10]
44. Maintain preventive care during osteoporosis therapy
For patients receiving antiresorptive medications for osteoporosis indications, the 2011 ADA CSA expert panel identified an oral health program of sound hygiene practices and regular dental care as potentially the optimal approach for lowering MRONJ risk, though this does not guarantee prevention.
Worked example: An asymptomatic patient taking alendronate for osteoporosis continues routine hygiene and dental care rather than waiting for an extraction or jaw lesion; the clinician still investigates new findings instead of assuming prevention eliminates risk.
Mistake to avoid: Assuming an oral health program guarantees MRONJ will never develop in an osteoporosis patient.
Reference: [7]
45. Expect remodeling after implantation in healed sites
Even in a fully healed ridge, implant placement may be followed by buccolingual dimensional reduction during initial healing; reported buccal bone wall reductions of 0.3 to 1.8 mm were observed over follow-up up to 72 months. Contour change alone neither confirms nor excludes pathology.
Worked example: An implant in a ridge healed for eight months shows a flatter buccal contour at review; the clinician assesses the cause and monitors rather than labeling it harmless remodeling or peri-implantitis.
Mistake to avoid: Assuming a ridge healed for months before placement cannot undergo further buccolingual reduction.
Reference: [4]
Oral pathology and oral medicine
46. Persistent red and white lesions require investigation
Leukoplakia, erythroplakia and their mixed forms are classified as oral potentially malignant disorders; color alone does not confer that classification. Erythroplakic components carry much greater malignant potential, though most leukoplakias do not progress. Patches unresolved after two weeks warrant reevaluation and consideration of biopsy.
Worked example: A 62-year-old patient has a mixed red-and-white tongue patch persisting three weeks; because erythroplakic components carry greater malignant potential, the clinician reevaluates and considers biopsy or referral rather than dismissing the painless patch.
Mistake to avoid: Postponing evaluation of a suspicious red-and-white patch solely because it causes the patient no pain.
Reference: [11]
47. Biopsy remains the diagnostic reference standard
For oral potentially malignant disorders and oral squamous cell carcinoma, biopsy remains the reference standard for diagnosis. Cytology adjuncts have only a limited conditional role for adults with an oral cavity or lip mucosal abnormality: they should not determine the need for biopsy or referral, but may be offered when biopsy is not possible, advisable or indicated, to further inform that need, particularly for clinically worrisome abnormalities. Vital staining and light-based adjuncts are not supported for determining which lesions require biopsy or referral, and persistence or progression requires biopsy or specialist referral despite negative cytology.
Worked example: A clinician documents an ulcerated, indurated floor-of-mouth lesion in a 58-year-old adult as a suspicious clinical impression rather than histologically confirmed cancer, and refers the patient for definitive tissue assessment because biopsy exceeds the practice's capability; a negative cytology result, if one were obtained, would not override the referral.
Mistake to avoid: Recording a visually suspicious oral lesion as biopsy-confirmed cancer without obtaining histological tissue diagnosis.
Reference: [11]
48. Negative cytology does not overrule persistence
Under the 2026 ADA guidance, cytology adjuncts should not determine biopsy or referral decisions for adult oral-cavity or lip mucosal abnormalities; use is limited to situations where biopsy is not possible, advisable or indicated. Persistence or progression warrants biopsy or referral despite negative cytology.
Worked example: A 49-year-old adult's lip abnormality enlarges after a negative cytology result obtained when biopsy was not advisable; following the 2026 ADA guidance, the clinician performs a biopsy or refers to a specialist despite that result.
Mistake to avoid: Using a negative cytology result to defer biopsy of an oral lesion that is clearly enlarging.
Reference: [11]
49. Light and staining adjuncts do not decide referral
The 2026 ADA guidance advises against using light-based or vital-staining adjuncts to determine biopsy or referral need for adult oral-cavity or lip abnormalities, or to screen asymptomatic adults, since reliance may cause unnecessary procedures or delayed diagnosis; these adjuncts remain distinct from histological diagnosis.
Worked example: An adult presents with a clinically worrisome tongue patch; a light-based device reads negative, but the clinician still proceeds with biopsy or specialist referral rather than letting the reassuring adjunct result delay assessment.
Mistake to avoid: Letting a negative light-based adjunct result delay biopsy of a suspicious lip lesion.
Reference: [11]
50. Medication exposure informs the jaw-lesion differential
Patient history and clinical examination remain the most sensitive diagnostic tools for MRONJ, so medication exposure must be established while considering alternatives such as alveolar osteitis, sinusitis, gingivitis/periodontitis, or periapical pathosis. MRONJ can also occur without dental intervention, so a preceding procedure is not required.
Worked example: A patient taking denosumab develops jaw pain with exposed bone after an extraction; the clinician documents the medication history, examines the site, and considers alveolar osteitis and periapical pathosis before reaching an MRONJ assessment.
Mistake to avoid: Diagnosing MRONJ automatically after any extraction in an antiresorptive patient without considering alternative diagnoses.
Reference: [7]
51. A persistent neck mass can signal oropharyngeal disease
Oropharyngeal squamous cell carcinoma may present as a neck mass from metastatic disease, sore throat, or dysphagia, and can grow undetected without overt symptoms. Findings persisting two weeks or more merit further investigation, though such findings raise concern without proving cancer.
Worked example: An adult reports a neck mass and swallowing difficulty persisting three weeks while the visible oral cavity appears unremarkable; the clinician pursues an appropriate referral pathway instead of dismissing concern based on the normal-appearing mouth.
Mistake to avoid: Dismissing oropharyngeal cancer concern because the visible oral cavity examination appears entirely normal.
Reference: [11]
Implant loading and provisional restorations
52. Immediate loading after late placement remains conditional
In the 2018 ITI framework, late placement with immediate loading (type 4A) may be considered only when patient-centered advantages exist and the criteria for immediate restoration/loading are met; early (4B) and conventional (4C) loading are the routine, well-documented options, and clinician skill must match the selected protocol.
Worked example: A patient asks for a faster restoration after late placement, but because the required immediate-loading criteria are unmet, the clinician plans type 4C conventional loading rather than adopting type 4A on preference alone.
Mistake to avoid: Treating a documented type 4A protocol as automatic entitlement to immediate loading for every late-placement patient.
Reference: [6]
53. Conventional loading is recommended with early placement
For early implant placement, the 2018 ITI consensus recommends conventional loading (type 2-3C) as the well-documented option, while immediate (2-3A) and early (2-3B) loading combined with early placement lack sufficient documentation for routine recommendation; insufficient documentation signals an evidence gap, not proof of inevitable failure.
Worked example: At a thin-facial-wall site planned for early placement with simultaneous augmentation, the clinician selects conventional loading because the consensus documents type 2-3C, not because immediate loading was shown to fail.
Mistake to avoid: Assuming early placement justifies early loading because the site appeared to heal well before connection.
Reference: [6]
54. Evaluate provisional contour and surface quality
In the 2023 Type 1A single-tooth maxillary esthetic-zone protocol, the provisional's emergence profile should be appropriate, neither over- nor under-contoured, and its surface should be highly polished; a satisfactory shade alone does not satisfy these contour and surface requirements.
Worked example: A provisional crown with a bulbous, over-contoured emergence profile and a rough, unpolished surface fails the protocol's requirements even though its shade blends convincingly with the neighboring teeth at delivery.
Mistake to avoid: Accepting an over-contoured provisional because its shade matches the adjacent teeth convincingly.
Reference: [5]
55. Respect provisional retention and loading conditions
For the 2023 Type 1A maxillary esthetic-zone provisional, ITI recommends screw retention, an occlusal scheme without eccentric contacts, light proximal contacts, and a retaining screw torqued according to the published guidelines of each manufacturer for the specific component; these provisional recommendations are not universal definitive-restoration rules.
Worked example: A screw-retained immediate provisional is delivered with no eccentric contacts, light proximal contacts, and its retaining screw tightened to the torque stated in the actual component manufacturer's published guidelines.
Mistake to avoid: Torquing the provisional screw to a remembered generic value instead of consulting the component manufacturer's published guidelines.
Reference: [5]
Periodontal and systemic relationships
56. Interpret the diabetes-periodontitis relationship cautiously
Hyperglycemia affects oral health, and periodontitis is associated with worse glycemic control, but the evidence is inconsistent, particularly in type 1 diabetes, so population associations should not become individual causal certainties.
Worked example: A dentist coordinating care for a patient who has both diabetes and severe periodontitis documents the association and arranges medical collaboration, without telling the patient that periodontal disease definitely caused her elevated HbA1c.
Mistake to avoid: Asserting that periodontal therapy will certainly lower an individual patient's HbA1c level.
Reference: [10]
57. Separate glycemic treatment effects from periodontal benefit
Evidence that periodontal treatment improves glycemic control is suggestive but inconsistent, with conflicting randomized trial results. An HbA1c reduction in one patient cannot be promised to another, attributed solely to periodontal care, or stated as a uniform expected effect; medical diabetes management continues.
Worked example: A patient with type 2 diabetes asks whether scaling and root planing will definitely lower her HbA1c; the clinician explains that trial results vary and her physician continues managing her glycemic control.
Mistake to avoid: Promising every treated patient the same HbA1c reduction reported in a single trial.
Reference: [10]
58. Recognize oral manifestations of uncontrolled diabetes
Uncontrolled diabetes can be associated with xerostomia, burning sensation, delayed wound healing, increased infections, candidiasis, parotid enlargement, gingivitis, and periodontitis; these are possible manifestations, so medical history review and appropriate medical assessment remain necessary.
Worked example: A patient with diabetes reports a dry mouth and a slowly healing extraction socket; the dentist reviews the medical history and control status rather than diagnosing uncontrolled diabetes from these nonspecific findings alone.
Mistake to avoid: Diagnosing inadequate diabetes control from parotid enlargement alone, skipping the medical history review entirely.
Reference: [10]
59. Recognize possible hypoglycemia without assuming warning
A hypoglycemic event can arise without initial visible signs, and patients may not recognize their own symptoms; mood changes, unusual behavior, or profuse sweating are clues prompting glucometer testing and the office's established protocol.
Worked example: During a scheduled appointment, a usually calm patient becomes irritable and sweats profusely; trained staff test her blood glucose with a glucometer and follow the office protocol for managing hypoglycemia.
Mistake to avoid: Assuming a patient will announce hypoglycemia and delaying glucometer testing until visible collapse occurs.
Reference: [10]
60. Weigh fracture prevention against MRONJ risk
For osteoporosis indications, the ADA holds that antiresorptive treatment benefits outweigh the low risk of MRONJ, a rare but serious adverse effect, because osteoporosis-related fractures carry considerable morbidity and mortality.
Worked example: When a dentist learns a patient takes an antiresorptive agent for osteoporosis, awareness of MRONJ warrants an oral-risk discussion, not a conclusion that the prescription is inherently unfavorable or should be abandoned.
Mistake to avoid: Advising a patient to stop her osteoporosis medication because MRONJ is a possible adverse effect.
Reference: [7]
Sources
- ABP Qualifying Examination: 2027 Blueprint Change, Format and Dates
- ABP Qualifying Exam 2027: Domains and Objectives
- Periodontitis: Consensus Report of Workgroup 2 of the 2017 World Workshop
- ITI 2023 Consensus: Influence of Buccal Bone Wall Thickness on Peri-Implant Hard and Soft Tissue Dimensional Changes
- ITI 2023 Consensus: Selection Criteria for Immediate Implant Placement and Immediate Loading in the Maxillary Esthetic Zone
- ITI 2018 Consensus: Implant Placement and Loading Protocols
- ADA: Osteoporosis Medications and Medication-Related Osteonecrosis of the Jaw
- ADA: Oral Anticoagulant and Antiplatelet Medications and Dental Procedures
- ADA: Antibiotic Prophylaxis Prior to Dental Procedures
- ADA: Diabetes—Periodontal Relationships and Dental Management
- ADA: Cancer of the Head and Neck—Clinical Evaluation and Referral
- CDC: Standard Precautions in Dental Settings
- CDC Principles of Epidemiology: Analytic Epidemiology—Experimental, Cohort and Case-Control Studies